FDA approves new injection to treat hives
Note: this article is provided by ONU Healthwise Pharmacy.
There's a newly approved treatment for hives.
The US Food and Drug Administration (FDA) has approved Quzyttir (cetirizine) to treat acute urticaria (hives).
Available as an injection to be given into the vein (IV), this new medication is approved for adults and children 6 months of age and older.
Cetirizine injection is now an alternative treatment option to IV diphenhydramine (brand name Benadryl).
The approved dose is once every 24 hours as needed for acute hives.
This approval comes after cetirizine injection was shown to be effective in a clinical trial that included 262 adults with hives. Some patients received cetirizine injection, while others received diphenhydramine injection.
Common side effects may include headache, altered taste, feeling hot, indigestion and excessive sweating. This medication may cause drowsiness. Be cautious if driving or operating heavy machinery.
Speak with your health care provider if you have any questions about hives or the available treatments.
Stories Posted This Week
Sunday, August 30, 2026
Saturday, August 29, 2026
Friday, August 28, 2026
Thursday, August 27, 2026
- One seriously injured in Union Township crash
- President Sider introduces Reinvest, Reinvent, Reimagine framework in State of the University
- Bluffton girls tennis loss vs. Wapakoneta
- Pirate volleyball sweeps Rockets
- EMS Chief Noah Babcock is Sept. 1 Bluffton Lions speaker
- Mercy Mercy Me (The Ecology): Air pollution and rheumatoid arthritis
Wednesday, August 26, 2026
- Ohio fall hunting season begins Sept. 1
- Aug. 24 Bluffton Council recap: MHCO duplexes and long range Village planning
- Beaverdam installs AED at village park
- Pirate girls tennis edges St. Mary
- Pirate boys soccer tames Bearcats
- WIP Wednesday: Window on your world
- OPEN POLL: What do farmers wish non-farmers knew?
- 2026 PorchFest preview: LeBlanc Zepplin, CAWZ, Marlena Rock